Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference
August 09 2021 - 07:55AM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”)
today announced that members of the executive management team will
participate in a fireside chat during the Virtual BTIG Annual
Biotech Conference on Tuesday, August 10, 2021 at 2:50 p.m. ET.
In order to participate in the audio webcast, interested parties
can access the live webcast under "News/Events” through the
“Investors” section of the Aurinia corporate website at
www.auriniapharma.com. A replay of the webcast will be available on
Aurinia’s website.
ABOUT AURINIA
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical
company focused on delivering therapies to treat targeted patient
populations that are impacted by serious diseases with a high unmet
medical need. The Company has introduced LUPKYNIS™ (voclosporin),
the first FDA-approved oral therapy dedicated for the treatment of
adult patients with active lupus nephritis (LN). The Company’s head
office is in Victoria, British Columbia, its U.S. commercial hub is
in Rockville, Maryland, and the Company focuses its development
efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210809005377/en/
Investor Contact: Glenn Schulman, PharmD, MPH SVP,
Corporate Communications & IR gschulman@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2023 to Mar 2024